Matrix Capital Management Company, LP - Sep 30, 2025 SCHEDULE 13G/A Report for Maze Therapeutics, Inc. Common Stock, par value $0.001 per share (MAZE)

Filing Manager
Matrix Capital Management Company, LP
Reporting Manager
Matrix Capital Management Company, LP
Security
Maze Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
MAZE
Shares outstanding
47.2M shares
Disclosed Ownership
1.65M shares
Ownership
3.5%
Form type
SCHEDULE 13G/A
Date filed
11/13/2025, 04:10 PM
Date of event
Sep 30, 2025
Previous filing
May 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Matrix Capital Management Company, LP 3.5% 1.65M 0 1.65M /s/ David E. Goel David E. Goel, Managing General Partner
DAVID E. GOEL 3.5% 1.65M 0 1.65M /s/ David E. Goel David E. Goel, individually